PMOS affects 10–13% of women and involves genetic, epigenetic, endocrine, metabolic, inflammatory, and reproductive factors. Better screening, clinical awareness, and proactive, specialized treatment strategies can improve pregnancy and birth outcomes for women with PMOS (PCOS).
New content online: Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes
dlvr.it/TSvNXN